News

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune response than having it in the opposite arm, according to a study in mice ...
Now Trump wants to end its ‘woke AI’ efforts Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine after the agency grants ...
TL: Kind of both. Vaccine hesitancy, vaccine resistance, vaccine rejection is as old as — and, in some senses, older than — vaccines themselves. Prior to true vaccines, you had people ...
A vaccine that does not need to be kept in a fridge or frozen has entered its first clinical trial. The Stablepharma tetanus-diphtheria vaccine (SPVX02) is completely stable at room temperature ...
Other vaccine approvals possibly at risk Novavax’s shot isn’t the only Covid vaccine that officials say may be at risk. Dr. Tracy Beth Høeg, who was announced as a special adviser to Makary ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the ...
“I don’t think because there’s a strain change that this is a new product,” said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief. If that’s the new ...
Some words may be mispronounced. DES MOINES — Iowa K-12 schools and licensed child care centers would be required to disclose vaccine exemption information on their websites and include it in ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...
The two-dose measles mumps and rubella (MMR) vaccine is widely available, with the first dose recommended for children between the ages of 12 and 15 months and the second dose recommended between ...